An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients (Q57658599)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients |
article |
Statements
An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients (English)
J Fauvel
E Bonnet
J B Ruidavets
A Toffoletti
P Massip
H Chap
1 December 2001